Florentin, Jonathan
Zhao, Jingsi
Tai, Yi-Yin
Vasamsetti, Sathish Babu
O’Neil, Scott P.
Kumar, Rahul
Arunkumar, Anagha
Watson, Annie
Sembrat, John
Bullock, Grant C.
Sanders, Linda
Kassa, Biruk
Rojas, Mauricio
Graham, Brian B.
Chan, Stephen Y.
Dutta, Partha
Funding for this research was provided by:
American Heart Association (19IPLOI34760566, 19CDA34730030)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R00HL12076, T32)
American Lung Association (IA-629694)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 6 March 2020
Accepted: 21 November 2020
First Online: 8 January 2021
Competing interests
: S.Y.C. has served as a consultant for Zogenix, Aerpio, and United Therapeutics. S.Y.C. holds research grants from Actelion and Pfizer. S.Y.C. has filed patent applications regarding the targeting of metabolism in PH. The authors declare no other competing interests.